Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

150.00p
   
  • Change Today:
      3.00p
  • 52 Week High: 151.50
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.82m
  • Volume: 1,172,605
  • Market Cap: £127.23m
  • RiskGrade: 196

Deal with Barclays    Trade now with Barclays Stockbrokers

Diaceutics Overview

Diaceutics is a data analytics and implementation services company which services the global pharmaceutical industry. It has established a suite of data-driven products and implementation services powered by the data held in its proprietary database. Its products and services are focused on optimising its clients’ strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. The Group currently provides services to 20 of the 30 largest global pharmaceutical companies.
Competitors: Mediclinic International , Open Orphan , Cambridge Cognition Holdings, Tristel, Sourcebio International, CareTech Holding, Trellus Health

Key Personnel

CEO: Ryan Gerard Keeling
CFO: Nick Roberts
Executive Director: Peter Keeling
Executive Director: Jordan Clark
Independent Non-Executive Director: Richard Charles Hindson
Non-Executive Dir: Graham Paterson, Cheryl MacDiarmid

Contact Details

Address: First Floor, Building Two, Dataworks at Kings Hall Health and Wellbeing Park, Belfast, County Antrim, United Kingdom, BT9 6GW
Website: http://www.diaceutics.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BJQTGV64

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 150.00p
Change Today 3.00p
% Change 2.04 %
52 Week High 151.50
52 Week Low 108.00
Volume 1,172,605
Shares Issued 84.82m
Market Cap £127.23m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Trend
29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income Not Available
Growth
48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for 19-Sep-2025

Time Volume / Share Price
14:45 87,296 @ 151.00p
14:45 75,000 @ 151.00p
13:27 64,145 @ 149.05p
15:14 628,756 @ 150.00p
15:04 8,648 @ 150.25p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page